http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103304566-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-18
filingDate 2013-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103304566-B
titleOfInvention A kind of crystallization type Entecavir
abstract The present invention relates to the preparation method of a kind of new crystallization type Entecavir and this crystallization type Entecavir, the X-ray powder diffraction figure of described new crystallization type Entecavir is in 2 θ=16.435 ° (d=5.38925), 2 θ=19.704 ° (d=4.50199), there is stronger diffraction peak at ° (d=3.50703) place, 2 θ=25.376, on differential thermal analysis collection of illustrative plates, start to occur a dehydration endotherm melting peak at 79.1 DEG C, an endothermic melting peak is there is at 140.1 DEG C, at the endothermic melting peak that about 244.6 DEG C appearance one are sharp-pointed, during to about 299.2 DEG C, sample starts to dissolve.Crystallization type Entecavir of the present invention when comparatively preparation is made in Entecavir hydrate crystallization, has better dissolution rate, and crystal formation has relatively better stability.
priorityDate 2013-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102596956-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418354341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454409456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73115
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID515951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5481350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135526609
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419561672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23978

Total number of triples: 43.